AAM
HRMY icon

Advisors Asset Management’s Harmony Biosciences HRMY Stock Holding History

Advisors Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
6,064
+76
+1% +$2.4K ﹤0.01% 1141
2026
Q1 		$168K Sell
5,988
-76
-1% -$2.49K ﹤0.01% 1181
2025
Q4 		$227K Sell
6,064
-4
-0.1% -$132 ﹤0.01% 1110
2025
Q3 		$167K Sell
6,068
-23
-0.4% -$792 ﹤0.01% 1146
2025
Q2 		$192K Buy
6,091
+3
+0% +$97 ﹤0.01% 1120
2025
Q1 		$202K Buy
6,088
+2,737
+82% +$98.1K ﹤0.01% 1106
2024
Q4 		$115K Sell
3,351
-12,918
-79% -$444K ﹤0.01% 1202
2024
Q3 		$651K Sell
16,269
-650
-4% -$22.8K 0.01% 848
2024
Q2 		$510K Sell
16,919
-5,997
-26% -$180K 0.01% 896
2024
Q1 		$770K Sell
22,916
-737
-3% -$23.7K 0.01% 802
2023
Q4 		$764K Sell
23,653
-2,095
-8% -$58.5K 0.02% 785
2023
Q3 		$844K Sell
25,748
-467
-2% -$16.2K 0.02% 760
2023
Q2 		$923K Buy
26,215
+2,817
+12% +$97.3K 0.02% 766
2023
Q1 		$764K Buy
23,398
+2,709
+13% +$123K 0.02% 839
2022
Q4 		$1.14M Buy
20,689
+15,361
+288% +$845K 0.02% 700
2022
Q3 		$236K Buy
5,328
+1,074
+25% +$52.4K ﹤0.01% 1107
2022
Q2 		$207K Buy
+4,254
New +$192K ﹤0.01% 1159

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisors Asset Management's HRMY Position: Q2 2026 in Review

Advisors Asset Management increased its Harmony Biosciences (HRMY) stake by 1.3% in Q2 2026, buying an estimated $2.4K and bringing the position to 6,064 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

Advisors Asset Management first reported a position in HRMY in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.14M in Q4 2022. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Advisors Asset Management held 6,064 shares of Harmony Biosciences worth $221K as of Q2 2026.
  • Advisors Asset Management bought 76 Harmony Biosciences shares in Q2 2026, an estimated $2.4K.
  • Harmony Biosciences made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1141 holding.
  • Advisors Asset Management first reported a position in Harmony Biosciences in Q2 2022 and has held it in 17 quarters since.
  • Advisors Asset Management's Harmony Biosciences position peaked at $1.14M in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.